Viracta, a California biotech oncology firm, is laying off every remaining employee and shutting down after its cash stores ...

Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

A Philadelphia biotechnology company founded seven years ago by two former Johnson & Johnson executives has a new leader. Susan Dillon has stepped down as president and CEO of Aro Biotherapeutics. She ...

Oxford Cannabinoid Technologies is shedding its old skin. Having delisted its stock last year, the biotech is rebranding as ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

The aggregate gross proceeds to the Company from the offering are expected to be approximately $1.05 million, before ...

Biotech firm Phytome Life Sciences plans to establish a headquarters in Saudi Arabia in a bid to accelerate commercialization ...

For example, Brittany found that drugs being developed by Generate were modified versions of existing antibodies, and that ...

The fund aims to build a portfolio of 20-25 companies that address gaps in services and products across pharmaceuticals, ...